These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20827191)

  • 41. Analysis of oxidized and chlorinated lipids by mass spectrometry and relevance to signalling.
    Spickett CM; Fauzi NM
    Biochem Soc Trans; 2011 Oct; 39(5):1233-9. PubMed ID: 21936795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.
    Mendel I; Shoham A; Propheta-Meiran O; Ishai E; Halperin G; Feige E; Breitbart E
    J Neuroimmunol; 2010 Sep; 226(1-2):126-35. PubMed ID: 20663571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural identification and cardiovascular activities of oxidized phospholipids.
    Salomon RG
    Circ Res; 2012 Sep; 111(7):930-46. PubMed ID: 22982874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filarial nematode secreted product ES-62 is an anti-inflammatory agent: therapeutic potential of small molecule derivatives and ES-62 peptide mimetics.
    Harnett W; Harnett MM
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):511-8. PubMed ID: 16700887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage.
    Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N
    Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ACTH: The forgotten therapy.
    Montero-Melendez T
    Semin Immunol; 2015 May; 27(3):216-26. PubMed ID: 25726511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of oxidized phospholipids on the structural and dynamic organization of phospholipid membranes: a combined DSC and solid state NMR study.
    Wallgren M; Beranova L; Pham QD; Linh K; Lidman M; Procek J; Cyprych K; Kinnunen PK; Hof M; Gröbner G
    Faraday Discuss; 2013; 161():499-513; discussion 563-89. PubMed ID: 23805755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis.
    Rahmani F; Rezaei N
    Expert Rev Clin Immunol; 2016 Dec; 12(12):1289-1298. PubMed ID: 27359083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
    Curtiss LK; Tobias PS
    Curr Drug Targets; 2007 Dec; 8(12):1230-8. PubMed ID: 18220700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Therapeutic treatment with Ibrutinib attenuates imiquimod-induced psoriasis-like inflammation in mice through downregulation of oxidative and inflammatory mediators in neutrophils and dendritic cells.
    Al-Harbi NO; Nadeem A; Ahmad SF; Bakheet SA; El-Sherbeeny AM; Ibrahim KE; Alzahrani KS; Al-Harbi MM; Mahmood HM; Alqahtani F; Attia SM; Alotaibi MR
    Eur J Pharmacol; 2020 Jun; 877():173088. PubMed ID: 32234429
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidized Phospholipids in Healthy and Diseased Lung Endothelium.
    Karki P; Birukov KG
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oxidized PLs and vascular inflammation.
    Aldrovandi M; O'Donnell VB
    Curr Atheroscler Rep; 2013 May; 15(5):323. PubMed ID: 23512607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BX471: a CCR1 antagonist with anti-inflammatory activity in man.
    Horuk R
    Mini Rev Med Chem; 2005 Sep; 5(9):791-804. PubMed ID: 16178722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of the cholinergic anti-inflammatory pathway on collagen-induced arthritis involves the modulation of dendritic cell differentiation.
    Liu D; Li T; Luo H; Zuo X; Liu S; Wu S
    Arthritis Res Ther; 2018 Nov; 20(1):263. PubMed ID: 30486874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.
    Mendel I; Yacov N; Shoham A; Ishai E; Breitbart E
    Dig Dis Sci; 2016 Sep; 61(9):2545-53. PubMed ID: 27074921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics.
    Gomariz RP; Gutiérrez-Cañas I; Arranz A; Carrión M; Juarranz Y; Leceta J; Martínez C
    Curr Pharm Des; 2010; 16(9):1063-80. PubMed ID: 20030612
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensing environmental lipids by dendritic cell modulates its function.
    Coutant F; Agaugué S; Perrin-Cocon L; André P; Lotteau V
    J Immunol; 2004 Jan; 172(1):54-60. PubMed ID: 14688309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanism of oxidized phospholipid-related inflammatory response in vascular ageing.
    Wang T; Wang Y; Zhang X; Xu W; Jin K; Pang Y; Wu Y; Luo J; Xu R; Jiao L; Li W
    Ageing Res Rev; 2023 Apr; 86():101888. PubMed ID: 36806379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.